FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

385112003: Conventional release cutaneous powder (dose form)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1479374014 Cutaneous powder en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3559622012 Conventional release cutaneous powder (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3559623019 Conventional release cutaneous powder en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cutaneous powder Is a Cutaneous AND/OR transdermal dosage form false Inferred relationship Some
Cutaneous powder Is a Drug powder false Inferred relationship Some
Cutaneous powder Is a Cutaneous dose form true Inferred relationship Some
Cutaneous powder Has dose form administration method (attribute) Apply (administration method) true Inferred relationship Some
Cutaneous powder Has dose form intended site (attribute) Cutaneous (intended site) true Inferred relationship Some
Cutaneous powder Has dose form release characteristic (attribute) Conventional release (release characteristic) true Inferred relationship Some
Cutaneous powder Has basic dose form (attribute) Powder (basic dose form) true Inferred relationship Some
Cutaneous powder Has dose form transformation (attribute) No transformation true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Cutaneous powder spray Is a False Cutaneous powder Inferred relationship Some
Nystatin 100 unit/mg cutaneous powder Has manufactured dose form True Cutaneous powder Inferred relationship Some
Streptokinase+streptodornase 100,000/25,000units topical powder Has manufactured dose form False Cutaneous powder Inferred relationship Some
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) Has manufactured dose form True Cutaneous powder Inferred relationship Some
Undecylenic acid 50 microgram/mg and zinc undecylenate 200 microgram/mg cutaneous powder Has manufactured dose form True Cutaneous powder Inferred relationship Some
Tolnaftate 10 mg/g cutaneous powder Has manufactured dose form True Cutaneous powder Inferred relationship Some
Mafenide acetate 5% powder Has manufactured dose form False Cutaneous powder Inferred relationship Some
Chlorhexidine diacetate 10 mg/g cutaneous powder Has manufactured dose form True Cutaneous powder Inferred relationship Some
Product containing precisely clotrimazole 10 milligram/1 gram conventional release cutaneous powder (clinical drug) Has manufactured dose form True Cutaneous powder Inferred relationship Some
Salicylic acid+boric acid 3%/5% conventional release cutaneous powder Has manufactured dose form False Cutaneous powder Inferred relationship Some
Product containing precisely salicylic acid 50 microgram/1 milligram and zinc oxide 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) Has manufactured dose form True Cutaneous powder Inferred relationship Some
Miconazole nitrate 20 mg/g cutaneous powder Has manufactured dose form True Cutaneous powder Inferred relationship Some
Calcium carbonate 900 mg/g cutaneous powder Has manufactured dose form True Cutaneous powder Inferred relationship Some
Calcium undecylenate 100 mg/g cutaneous powder Has manufactured dose form True Cutaneous powder Inferred relationship Some
Product containing precisely povidone iodine 50 milligram/1 gram conventional release cutaneous powder (clinical drug) Has manufactured dose form True Cutaneous powder Inferred relationship Some
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder Has manufactured dose form True Cutaneous powder Inferred relationship Some
Product containing precisely zinc undecylenate 100 milligram/1 gram conventional release cutaneous powder (clinical drug) Has manufactured dose form True Cutaneous powder Inferred relationship Some
Product containing precisely econazole nitrate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) Has manufactured dose form True Cutaneous powder Inferred relationship Some

This concept is not in any reference sets

Back to Start